Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice.

Published in: Diabetes, obesity & metabolism (2023)

We conclude that sPIF is a promising secretagogue for the treatment of T2D.

Keyphrases